TETANUS, DIPHTHERIA AND ACELLULAR PERTUSSIS VACCINATION

Clinical trials for TETANUS, DIPHTHERIA AND ACELLULAR PERTUSSIS VACCINATION explained in plain language.

Never miss a new study

Get alerted when new TETANUS, DIPHTHERIA AND ACELLULAR PERTUSSIS VACCINATION trials appear

Sign up with your email to follow new studies for TETANUS, DIPHTHERIA AND ACELLULAR PERTUSSIS VACCINATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New booster shot trial aims to protect against three dangerous diseases

⭐️ VACCINE ⭐️ Not yet recruiting

This study is testing a new version of the Tdap vaccine, which protects against tetanus, diphtheria, and whooping cough (pertussis). Researchers want to see if this vaccine, which contains fewer antigens, is safe and triggers a good immune response in people aged 6 years and olde…

Matched conditions: TETANUS, DIPHTHERIA AND ACELLULAR PERTUSSIS VACCINATION

Phase: PHASE1, PHASE2 • Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️

Last updated Apr 01, 2026 14:43 UTC

TETANUS, DIPHTHERIA AND ACELLULAR PERTUSSIS VACCINATION

Get alerted when new TETANUS, DIPHTHERIA AND ACELLULAR PERTUSSIS VACCINATION trials appear

New booster shot trial aims to protect against three dangerous diseases